Effects of free access to sugar solutions on the control of energy intake

References

• Polednak, A.P. Trends in incidence rates for obesity-associated cancers in the US. Cancer Detect. Prev. 2003, 27, 415–421.
   PubMedGoogle Scholar
• Zimmet, P.; Alberti, K.; Shaw, J. Global and societal implications of the diabetes epidemic. Nature. 2001, 414, 782–787.
   PubMed Web of Science ®Google Scholar
• Hall, M.E.; Obesity, hypertension, and chronic kidney disease. International Journal of Nephrology and Renovascular Disease 2014, 7, 75.
   PubMedGoogle Scholar
• Lavie, C.J.; McAuley, P.A.; Church, T.S.; Milani, R.V.; Blair, S.N.;do Carmo, J.M.; da Silva, A.A.; Juncos, L.A.; Wang, Z.; Hall, J.E. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J. Am. College Cardiol. 2014, 63, 1345–1354.
   PubMed Web of Science ®Google Scholar
• Ogden, C.L.; Carroll, M.D.; Kit, B.K.; Flegal, K.M. Prevalence of obesity in the United States, 2009-2010. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics Hyattsville, MD. 2012.
   Google Scholar
• Benicky, J.; Sánchez-Lemus, E.; Honda, M.; Pang, T.; Orecna, M.; Wang, J.; Leng, Y.; Chuang, D.-M.; Saavedra, J.M. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 2011, 36, 857–870.
   PubMed Web of Science ®Google Scholar
• Hinnouho, G.-M.; Czernichow, S.; Dugravot, A.; Batty, G.D.; Kivimaki, M.; Singh-Manoux, A. Metabolically healthy obesity and risk of mortality does the definition of metabolic health matter? Diabetes Care 2013, 36, 2294–2300.
   PubMed Web of Science ®Google Scholar
• Crino, M.; Sacks, G.; Vandevijvere, S.; Swinburn, B.; Neal, B. The influence on population weight gain and obesity of the macronutrient composition and energy density of the food supply. Curr. Obesity Rep. 2015, 4, 1–10.
   Google Scholar
• Kral, T.V.; Roe, L.S.; Rolls, B.J. Combined effects of energy density and portion size on energy intake in women. Am. J. Clin. Nutr. 2004, 79, 962–968.
   PubMed Web of Science ®Google Scholar
• Tillman, E.J.; Morgan, D.A.; Rahmouni, K.; Swoap, S.J. Three months of high-fructose feeding fails to induce excessive weight gain or leptin resistance in mice. PloS one 2014, 9, e107206.
   PubMed Web of Science ®Google Scholar
• Frayling, T.M.; Timpson, N.J.; Weedon, M.N.; Zeggini, E.; Freathy, R.M.; Lindgren, C.M.; Perry, J.R.; Elliott, K.S.; Lango, H.; Rayner, N.W. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316, 889–894.
   PubMed Web of Science ®Google Scholar
• Clément, K.; Vaisse, C.; Lahlou, N.; Cabrol, S.; Pelloux, V.; Cassuto, D.; Gourmelen, M.; Dina, C.; Chambaz, J.; Lacorte, J.-M. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392, 398–401.
   PubMed Web of Science ®Google Scholar
• Mota, J.; Fidalgo, F.; Silva, R.; Ribeiro, J.C.; Santos, R.; Carvalho, J.; Santos, M.P. Relationships between physical activity, obesity and meal frequency in adolescents. Ann. Hum. Biol. 2008, 35, 1–10.
   PubMed Web of Science ®Google Scholar
• Oishi, K.; Higo-Yamamoto, S. Disrupted daily light–dark cycles induce physical inactivity and enhance weight gain in mice depending on dietary fat intake. NeuroReport 2014, 25, 865–869.
   Web of Science ®Google Scholar
• Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.-H.; Gersch, M.S.; Benner, S.; Sánchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899–906.
   PubMed Web of Science ®Google Scholar
• Gower, B.A.; Goss, A.M.; A Lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J. Nutr. 2015, 145, 177S–183S.
   PubMed Web of Science ®Google Scholar
• Nordmann, A.J.; Nordmann, A.; Briel, M.; Keller, U.; Yancy, W.S.; Brehm, B.J.; Bucher, H.C.; Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch. Int. Med. 2006, 166, 285–293.
   PubMed Web of Science ®Google Scholar
• Ventura, E.E.; Davis, J.N.; Goran, M.I.; Sugar content of popular sweetened beverages based on objective laboratory analysis: focus on fructose content. Obesity. 2011, 19, 868–874.
   PubMed Web of Science ®Google Scholar
• Walker, R.W.; Dumke, K.A.; Goran, M.I.; Fructose content in popular beverages made with and without high-fructose corn syrup. Nutrition 2014, 30, 928–935.
   PubMed Web of Science ®Google Scholar
• Bray, G.A.; Nielsen, S.J.; Popkin, B.M.; Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. The American Journal of Clinical Nutrition. 2004, 79, 537–543.
   PubMed Web of Science ®Google Scholar
• Malik, V.; Hu, F. sweeteners and risk of obesity and type 2 diabetes: the role of sugar-sweetened beverages. Curr. Diabetes Rep. 2012, 12, 195–203.
   Web of Science ®Google Scholar
• Chiavaroli, L.; Ha, V.; de Souza, R.J.; Kendall, C.W.; Sievenpiper, J.L.; Fructose in obesity and cognitive decline: is it the fructose or the excess energy? Nutr. J. 2014, 13, 27.
   Google Scholar
• Forshee, R.A.; Storey, M.L.; Allison, D.B.; Glinsmann, W.H.; Hein, G.L.; Lineback, D.R.; Miller, S.A.; Nicklas, T.A.; Weaver, G.A.; White, J.S.; A critical examination of the evidence relating high fructose corn syrup and weight gain. Critical reviews in food science and nutrition. 2007, 47, 561–582.
   PubMed Web of Science ®Google Scholar
• Bray, G.; Popkin, B. Calorie‐sweetened beverages and fructose: what have we learned 10 years later. Pediat. Obesity 2013, 8, 242–248.
   PubMed Web of Science ®Google Scholar
• Nakagawa, T.; Tuttle, K.R.; Short, R.A.; Johnson, R.J.; Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat. Clin. Pract. Neph. 2005, 1, 80–86.
   PubMedGoogle Scholar
• Stanhope, K.L.; Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Ann. Rev. Med. 2012, 63, 329–343.
   PubMed Web of Science ®Google Scholar
• Vos, M.B.; Kimmons, J.E.; Gillespie, C.; Welsh, J.; Blanck, H.M.; Dietary fructose consumption among US children and adults: the third national health and nutrition examination survey. Medscape J. Med. 2008, 10, 160–160.
   PubMedGoogle Scholar
• Gao, H.; Guan, T.; Li, C.; Zuo, G.; Yamahara, J.; Wang, J.; Li, Y. Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway. Evidence-Based Complementary and Alternative Medicine 2012, 2012, 1–12.
   Google Scholar
• Mellor, K.M.; Bell, J.R.; Young, M.J.; Ritchie, R.H.; Delbridge, L.M.D. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J. Mol. Cell. Cardiol. 2011, 50, 1035–1043.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lozada, L.G.; Tapia, E.; Jiménez, A.; Bautista, P.; Cristóbal, M.; Nepomuceno, T.; Soto, V.; Ávila-Casado, C.; Nakagawa, T.; Johnson, R.J. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol.-Renal Physiol. 2007, 292, F423–F429.
   PubMed Web of Science ®Google Scholar
• Iannelli, A.; Anty, R.; Schneck, A.S.; Tran, A.; Gugenheim, J. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery. 2011, 149, 364–370.
   PubMed Web of Science ®Google Scholar
• Blevins, J.E.; Graham, J.L.; Morton, G.J.; Bales, K.L.; Schwartz, M.W.; Baskin, D.G.; Havel, P.J. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am. J. Physiol. Regul. Integ. Compar. Physiol. 2015, 308, R431–R438
   PubMed Web of Science ®Google Scholar
• Nakagawa, T.; Hu, H.; Zharikov, S.; Tuttle, K.R.; Short, R.A.; Glushakova, O.; Ouyang, X.; Feig, D.I.; Block, E.R.; Herrera-Acosta, J. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol.-Renal Physiol. 2006, 290, F625–F631.
   PubMed Web of Science ®Google Scholar
• Xu, X.; Zhao, C.X.; Wang, L.; Tu, L.; Fang, X.; Zheng, C.; Edin, M.L.; Zeldin, D.C.; Wang, D.W. Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes 2010, 59, 997–1005.
   PubMed Web of Science ®Google Scholar
• Page, K.A.; Chan, O.; Arora, J.; Belfort-DeAguiar, R.; Dzuira, J.; Roehmholdt, B.; Cline, G.W.; Naik, S.; Sinha, R.; Constable, R.T. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathwaysfructose consumption and weight gain. JAMA. 2013, 309, 63–70.
   PubMed Web of Science ®Google Scholar
• Erlanson-Albertsson, C.; Lindqvist, A. Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids. Regul. Peptides. 2010, 161, 87–91.
   PubMedGoogle Scholar
• Gersch, M.S.; Mu, W.; Cirillo, P.; Reungjui, S.; Zhang, L.; Roncal, C.; Sautin, Y.Y.; Johnson, R.J.; Nakagawa, T. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am. J. Physiol.-Renal Physiol. 2007, 293, F1256–F1261.
   PubMed Web of Science ®Google Scholar
• Niewoehner, C.B. Metabolic effects of dietary versus parenteral fructose. J. Am. College Nutr. 1986, 5, 443–450.
   PubMed Web of Science ®Google Scholar
• Epstein, L.H.; Gordy, C.C.; Raynor, H.A.; Beddome, M.; Kilanowski, C.K.; Paluch, R. Increasing fruit and vegetable intake and decreasing fat and sugar intake in families at risk for childhood obesity. Obesity Res. 2001, 9, 171–178.
   PubMedGoogle Scholar
• He, K.; Hu, F.B.; Colditz, G.A.; Manson, J.E.; Willett, W.C.; Liu, S. Changes in intake of fruits and vegetables in relation to risk of obesity and weight gain among middle-aged women. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 1569–1574.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio, J.J.; Lucan, S.C. The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart 2014, 1, e000167.
   PubMedGoogle Scholar
• van Buul, V.J.; Tappy, L.; Brouns, F.J. Misconceptions about fructose-containing sugars and their role in the obesity epidemic. Nutr. Res. Rev. 2014, 27, 119–130.
   PubMed Web of Science ®Google Scholar
• Varady, K.A.; Dam, V.T.; Klempel, M.C.; Horne, M.; Cruz, R.; Kroeger, C.M.; Santosa, S. Effects of weight loss via high fat vs. low fat alternate day fasting diets on free fatty acid profiles. Sci. Rep. 2015, 5.
   Google Scholar
• Wojnicki, F.; Stine, J.; Corwin, R. Liquid sucrose bingeing in rats depends on the access schedule, concentration and delivery system. Physiol. Behav. 2007, 92, 566–574.
   PubMed Web of Science ®Google Scholar
• Gaby, A.R. Adverse effects of dietary fructose. Alt. Med. Rev. 2005, 10, 294–306.
   PubMed Web of Science ®Google Scholar
• Goldin, A.; Beckman, J.A.; Schmidt, A.M.; Creager, M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006, 114, 597–605.
   PubMed Web of Science ®Google Scholar
• Born, P.; Zech, J.; Lehn, H.; Classen, M.; Lorenz, R. Colonic bacterial activity determines the symptoms in people with fructose-malabsorption. Hepato-Gastroenterol. 1994, 42, 778–785.
   Web of Science ®Google Scholar
• Lê, K.-A.; Faeh, D.; Stettler, R.; Ith, M.; Kreis, R.; Vermathen, P.; Boesch, C.; Ravussin, E.; Tappy, L. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 2006, 84, 1374–1379.
   PubMed Web of Science ®Google Scholar
• Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.; Dyachenko, A.; Zhang, W.; McGahan, J.P.; Seibert, A.; Krauss, R.M.; Chiu, S.; Schaefer, E.J.; Ai, M.; Otokozawa, S.; Nakajima, K.; Nakano, T.; Beysen, C.; Hellerstein, M.K.; Berglund, L.; Havel, P.J. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 2009, 119, 1322–1334.
   PubMed Web of Science ®Google Scholar
• Ackroff, K.; Sclafani, A. Rats’ preferences for high fructose corn syrup vs. sucrose and sugar mixtures. Physiol. Behav. 2011, 102, 548–552.
   PubMed Web of Science ®Google Scholar
• Rumessen, J.J. Fructose and related food carbohydrates: sources, intake, absorption, and clinical implications. Scand. J. Gastroenterol. 1992, 27, 819–828.
   PubMed Web of Science ®Google Scholar
• Le, M.T.; Frye, R.F.; Rivard, C.J.; Cheng, J.; McFann, K.K.; Segal, M.S.; Johnson, R.J.; Johnson, J.A. Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism 2012, 61, 641–651.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lozada, L.G.; Mu, W.; Roncal, C.; Sautin, Y.Y.; Abdelmalek, M.; Reungjui, S.; Le, M.; Nakagawa, T.; Lan, H.Y.; Yu, X. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur. J. Nutr. 2010, 49, 1–9.
   PubMed Web of Science ®Google Scholar
• Castonguay, T.W.; Hirsch, E.; Collier, G. Palatability of sugar solutions and dietary selection? Physiol. Behav. 1981, 27, 7–12.
   Google Scholar
• Soto, M.; Chaumontet, C.; Even, P.C.; Nadkarni, N.; Piedcoq, J.; Darcel, N.; Tomé, D.; Fromentin, G. Intermittent access to liquid sucrose differentially modulates energy intake and related central pathways in control or high-fat fed mice. Physiol. Behav. 2014
   PubMed Web of Science ®Google Scholar
• Thorburn, A.W.; Storlien, L.H.; Jenkins, A.B.; Khouri, S.; Kraegen, E. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am. J. Clin. Nutr. 1989, 49, 1155–1163.
   PubMed Web of Science ®Google Scholar
• Bocarsly, M.E.; Powell, E.S.; Avena, N.M.; Hoebel, B.G. High-fructose corn syrup causes characteristics of obesity in rats: Increased body weight, body fat and triglyceride levels. Pharmacol. Biochem. Behav. 2010, 97, 101–106.
   PubMed Web of Science ®Google Scholar
• Ishimoto, T.; Lanaspa, M.A.; Le, M.T.; Garcia, G.E.; Diggle, C.P.; MacLean, P.S.; Jackman, M.R.; Asipu, A.; Roncal-Jimenez, C.A.; Kosugi, T. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc. Natl. Acad. Sci. 2012, 109, 4320–4325.
   PubMed Web of Science ®Google Scholar
• Kawasaki, T.; Kashiwabara, A.; Sakai, T.; Igarashi, K.; Ogata, N.; Watanabe, H.; Ichiyanagi, K.; Yamanouchi, T. Long-term sucrose-drinking causes increased body weight and glucose intolerance in normal male rats. Br. J. Nutr. 2005, 93, 613–618.
   PubMed Web of Science ®Google Scholar
• Zheng, M.; Rangan, A.; Olsen, N.J.; Andersen, L.B.; Wedderkopp, N.; Kristensen, P.; Grøntved, A.; Ried-Larsen, M.; Lempert, S.M.; Allman-Farinelli, M.; Heitmann, B.L. Substituting sugar-sweetened beverages with water or milk is inversely associated with body fatness development from childhood to adolescence. Nutrition 2015, 31, 38–44.
   PubMed Web of Science ®Google Scholar
• Schwartz, M.W.; Woods, S.C.; Porte, D.; Seeley, R.J.; Baskin, D.G. Central nervous system control of food intake. Nature 2000, 404, 661–671.
   PubMed Web of Science ®Google Scholar
• Morton, G.J.; Meek, T.H.; Schwartz, M.W. Neurobiology of food intake in health and disease. Nat. Rev. Neurosci. 2014, 15, 367–378.
   PubMed Web of Science ®Google Scholar
• Tappy, L.; Lê, K.A.; Tran, C.; Paquot, N. Fructose and metabolic diseases: New findings, new questions. Nutrition (Burbank, Los Angeles County, Calif.). 2010, 26, 1044–1049.
   PubMed Web of Science ®Google Scholar
• London, E.; Castonguay, T.W. High fructose diets increase 11β-hydroxysteroid dehydrogenase type 1 in Liver and visceral adipose in rats within 24-h exposure. Obesity. 2011, 19, 925–932.
   PubMed Web of Science ®Google Scholar
• Swarbrick, M.M.; Stanhope, K.L.; Elliott, S.S.; Graham, J.L.; Krauss, R.M.; Christiansen, M.P.; Griffen, S.C.; Keim, N.L.; Havel, P.J. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br. J. Nutr. 2008, 100, 947–952.
   PubMed Web of Science ®Google Scholar
• Schultz, A.; Neil, D.; Aguila, M.; Mandarim-de-Lacerda, C. Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity. Int. J. Mol. Sci. 2013, 14, 21873–21886.
   PubMed Web of Science ®Google Scholar
• Zavaroni, I.; Chen, Y.-D.I.; Reaven, G.M. Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat. Metabolism 1982, 31, 1077–1083.
   PubMed Web of Science ®Google Scholar
• Campbell, E.S.; Castonguay, T.W. Fructose intake and circulating triglycerides: an examination of the roles of APOC 3 and FOXO1. FASEB J. 2013, 27, 1074.1078.
   PubMed Web of Science ®Google Scholar
• Stanhope, K.L.; Bremer, A.A.; Medici, V.; Nakajima, K.; Ito, Y.; Nakano, T.; Chen, G.; Fong, T.H.; Lee, V.; Menorca, R.I.; Keim, N.L.; Havel, P.J. Consumption of Fructose and High Fructose Corn Syrup Increase Postprandial Triglycerides, LDL-Cholesterol, and Apolipoprotein-B in Young Men and Women. J. Clin. Endocrinol. Metabol. 2011, 96, E1596–E1605.
   PubMed Web of Science ®Google Scholar
• Bista, B.; Beck, N. Cushing Syndrome. Indian J. Pediat. 2013, 1–7.
   Google Scholar
• Castonguay, T.W.; Dallman, M.; Stern, J.S. Corticosterone prevents body weight loss and diminished fat appetite following adrenalectomy. Nutr. Behav. 1984
   Google Scholar
• Bujalska, I.J.; Draper, N.; Michailidou, Z.; Tomlinson, J.W.; White, P.C.; Chapman, K.E.; Walker, E.A.; Stewart, P.M. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. J. Mol. Endocrinol. 2005, 34, 675–684.
   PubMed Web of Science ®Google Scholar
• Chapman, K.; Holmes, M.; Seckl, J. 11β-Hydroxysteroid Dehydrogenases: Intracellular Gate-Keepers of Tissue Glucocorticoid Action. Physiol. Rev. 2013, 93, 1139–1206.
   PubMed Web of Science ®Google Scholar
• Masuzaki, H.; Paterson, J.; Shinyama, H.; Morton, N.M.; Mullins, J.J.; Seckl, J.R.; Flier, J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294, 2166–2170.
   PubMed Web of Science ®Google Scholar
• Rask, E.; Olsson, T.; Soderberg, S.; Andrew, R.; Livingstone, D.E.; Johnson, O.; Walker, B.R. Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metabol. 2001, 86, 1418–1421.
   PubMed Web of Science ®Google Scholar
• Livingstone, D.E.W.; Walker, B.R. Is 11β-hydroxysteroid dehydrogenase type 1 a therapeutic target? effects of carbenoxolone in lean and obese zucker rats. J. Pharmacol. Exp. Therap. 2003, 305, 167–172.
   PubMed Web of Science ®Google Scholar
• Holmes, M.C.; Carter, R.N.; Noble, J.; Chitnis, S.; Dutia, A.; Paterson, J.M.; Mullins, J.J.; Seckl, J.R.; Yau, J.L. 11β-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments. J. Neurosci. 2010, 30, 6916–6920.
   PubMed Web of Science ®Google Scholar
• Masuzaki, H.; Yamamoto, H.; Kenyon, C.J.; Elmquist, J.K.; Morton, N.M.; Paterson, J.M.; Shinyama, H.; Sharp, M.G.F.; Fleming, S.; Mullins, J.J.; Seckl, J.R.; Flier, J.S. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J. Clin. Invest. 2003, 112, 83–90.
   PubMed Web of Science ®Google Scholar
• Morton, N.M.; Holmes, M.C.; Fiévet, C.; Staels, B.; Tailleux, A.; Mullins, J.J.; Seckl, J.R. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 2001, 276, 41293–41300.
   PubMed Web of Science ®Google Scholar
• Morton, N.M.; Paterson, J.M.; Masuzaki, H.; Holmes, M.C.; Staels, B.; Fievet, C.; Walker, B.R.; Flier, J.S.; Mullins, J.J.; Seckl, J.R. Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice. Diabetes. 2004, 53, 931–938.
   PubMed Web of Science ®Google Scholar
• Stewart, P.M.; Tomlinson, J.W. Cortisol, 11β-hydroxysteroid dehydrogenase type 1 and central obesity. Trend. Endocrinol. Metabol. 2002, 13, 94–96.
   PubMed Web of Science ®Google Scholar
• Fietta, P.; Fietta, P.; Delsante, G. Central nervous system effects of natural and synthetic glucocorticoids. Psychiat. Clin. Neurosci. 2009, 63, 613–622.
   PubMed Web of Science ®Google Scholar
• Verma, M.; Zhang, Z.; Mackellar, A.; Seckl, J.; Holmes, M.; Chapman, K. Decreased brain 11β-HSD1 expression following inflammation; a role in regulating brain energy homeostasis? Endo. Abst. 2014, 34, 243.
   Google Scholar
• Zakrzewska, K.E.; Cusin, I.; Stricker-Krongrad, A.; Boss, O.; Ricquier, D.; Jeanrenaud, B.; Rohner-Jeanrenaud, F. Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 1999, 48, 365–370.
   PubMed Web of Science ®Google Scholar
• Cusin, I.; Rouru, J.; Rohner‐Jeanrenaud, F. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic‐mediated obesity and insulin resistance. Obesity Res. 2001, 9, 401–406.
   PubMedGoogle Scholar
• Yi, C.-X.; Foppen, E.; Abplanalp, W.; Gao, Y.; Alkemade, A.; la Fleur, S.E.; Serlie, M.J.; Fliers, E.; Buijs, R.M.; Tschöp, M.H.; Kalsbeek, A. Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity. Diabetes 2012, 61, 339–345.
   PubMed Web of Science ®Google Scholar
• Hwang, I.-S.; Ho, H.; Hoffman, B.B.; Reaven, G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10, 512–516.
   PubMed Web of Science ®Google Scholar
• Drake, A.J.; Livingstone, D.E.; Andrew, R.; Seckl, J.R.; Morton, N.M.; Walker, B.R. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology 2005, 146, 913–919.
   PubMed Web of Science ®Google Scholar
• Morton, N.M.; Ramage, L.; Seckl, J.R. Down-regulation of adipose 11β-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology 2004, 145, 2707–2712.
   PubMed Web of Science ®Google Scholar
• Bursać, B.N.; Djordjevic, A.D.; Vasiljević, A.D.; Milutinović, D.D.V.; Veličković, N.A.; Nestorović, N.M.; Matić, G.M. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J. Nutr. Biochem. 2013, 24, 1166–1172.
   PubMed Web of Science ®Google Scholar
• Zhao, C.; Tschiffely, A.E.; Castonguay, T.W. Effect of sugars on mRNA expression of 11β-HSD1 in the hypothalamus of rats after 24 hour exposure. J. Agric. Life Sci. 2015, 2, 1–6.
   Google Scholar
• Baskin, D.G.; Lattemann, D.F.; Seeley, R.J.; Woods, S.C.; Porte, D.; Schwartz, M.W. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res. 1999, 848, 114–123.
   PubMed Web of Science ®Google Scholar
• Schwartz, M.W. Central nervous system of food intake. Nature 2000, 404, 661–671.
   PubMed Web of Science ®Google Scholar
• Sipols, A.J.; Baskin, D.G.; Schwartz, M.W. Effect of Intracerebroventricular Insulin Infusion on Diabetic Hyperphagia and Hypothalamic Neuropeptide Gene Expression. Diabetes 1995, 44, 147–151.
   PubMed Web of Science ®Google Scholar
• Brüning, J.C.; Gautam, D.; Burks, D.J.; Gillette, J.; Schubert, M.; Orban, P.C.; Klein, R.; Krone, W.; Müller-Wieland, D.; Kahn, C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289, 2122–2125.
   PubMed Web of Science ®Google Scholar
• Campbell, E.; Castonguay, T.W. Fructose Intake and Circulating Triglycerides: An Examination of the Role of APOC 3. J. Diabetes Obes. 2014, 1, 1–8.
   PubMedGoogle Scholar
• West, D.B.; Fey, D.; Woods, S.C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am. J. Physiol. 1984, 246, R776–R787.
   PubMed Web of Science ®Google Scholar
• Mehran, A.E.; Templeman, N.M.; Brigidi, G.S.; Lim, G.E.; Chu, K.-Y.; Hu, X.; Botezelli, J.D.; Asadi, A.; Hoffman, B.G.; Kieffer, T.J. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metabol. 2012, 16, 723–737.
   PubMed Web of Science ®Google Scholar
• Suga, A.; Hirano, T.; Kageyama, H.; Osaka, T.; Namba, Y.; Tsuji, M.; Miura, M.; Adachi, M.; Inoue, S. Effects of fructose and glucose on plasma leptin, insulin, and insulin resistance in lean and VMH-lesioned obese rats. AJP Endo and Metab. 2000, 278 (4), E677–E683.
   Google Scholar
• Lindqvist, A.; Baelemans, A.; Erlanson-Albertsson, C. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regulat. Peptides 2008, 150, 26–32.
   PubMedGoogle Scholar
• Teff, K.L.; Elliott, S.S.; Tschöp, M.; Kieffer, T.J.; Rader, D.; Heiman, M.; Townsend, R.R.; Keim, N.L.; D’Alessio, D.; Havel, P.J. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J. Clin. Endocrinol. Metabol. 2004, 89, 2963–2972.
   PubMed Web of Science ®Google Scholar
• Aeberli, I.; Hochuli, M.; Gerber, P.A.; Sze, L.; Murer, S.B.; Tappy, L.; Spinas, G.A.; Berneis, K. Moderate Amounts of Fructose Consumption Impair Insulin Sensitivity in Healthy Young Men A randomized controlled trial. Diabetes Care 2013, 36, 150–156.
   PubMed Web of Science ®Google Scholar
• Faeh, D.; Minehira, K.; Schwarz, J.-M.; Periasamy, R.; Park, S.; Tappy, L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005, 54, 1907–1913.
   PubMed Web of Science ®Google Scholar
• Lê, K.-A.; Ith, M.; Kreis, R.; Faeh, D.; Bortolotti, M.; Tran, C.; Boesch, C.; Tappy, L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 2009, 89, 1760–1765.
   PubMed Web of Science ®Google Scholar
• Lana, A.; Rodríguez-Artalejo, F.; Lopez-Garcia, E. Consumption of sugar-sweetened beverages is positively related to insulin resistance and higher plasma leptin concentrations in men and nonoverweight women. J. Nutr. 2014, 144, 1099–1105.
   PubMed Web of Science ®Google Scholar
• Hallfrisch, J.; Lazar, F.; Jorgensen, C.; Reiser, S. Insulin and glucose responses in rats fed sucrose or starch. Am. J. Clin. Nutr. 1979, 32, 787–793.
   PubMed Web of Science ®Google Scholar
• Bantle, J.P.; Raatz, S.K.; Thomas, W.; Georgopoulos, A. Effects of dietary fructose on plasma lipids in healthy subjects. Am. J. Clin. Nutr. 2000, 72, 1128–1134.
   PubMed Web of Science ®Google Scholar
• Holzl, B.; Paulweber, B.; Sandhofer, F.; Patsch, J. Hypertriglyceridemia and insulin resistance. J. Int. Med. 1998, 243, 79–82.
   PubMed Web of Science ®Google Scholar
• Samuel, V.T. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trend. Endocrinol. Metabol. 2011, 22, 60–65.
   PubMed Web of Science ®Google Scholar
• Huang, B.W.; Chiang, M.T.; Yao, H.T.; Chiang, W. The effect of high‐fat and high‐fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obesity Metabol. 2004, 6, 120–126.
   PubMed Web of Science ®Google Scholar
• Kinote, A.; Faria, J.A.; Roman, E.A.; Solon, C.; Razolli, D.S.; Ignacio-Souza, L.M.; Sollon, C.S.; Nascimento, L.F.; de Araújo, T.M.; Barbosa, A.P.L. Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels. Endocrinology 2012, 153, 3633–3645.
   PubMed Web of Science ®Google Scholar
• Calapai, G.; Corica, F.; Allegra, A.; Corsonello, A.; Sautebin, L.; Gregorio, T.; Rosa, M.; Costantino, G.; Buemi, M.; Caputi, A.P. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. Br. J. Pharmacol. 1998, 125, 798–802.
   PubMed Web of Science ®Google Scholar
• Lee, G.-H.; Proenca, R.; Montez, J.; Carroll, K.; Darvishzadeh, J.; Lee, J.; Friedman, J. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 389, 632–635.
   Google Scholar
• Erickson, J.C.; Hollopeter, G.; Palmiter, R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996, 274, 1704–1707.
   PubMed Web of Science ®Google Scholar
• Sindelar, D.K.; Havel, P.J.; Seeley, R.J.; Wilkinson, C.W.; Woods, S.C.; Schwartz, M.W. Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes 1999, 48, 1275–1280.
   PubMed Web of Science ®Google Scholar
• Shapiro, A.; Mu, W.; Roncal, C.; Cheng, K.-Y.; Johnson, R.J.; Scarpace, P.J. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am. J. Physiol.-Regulatory Integr. Comp. Physiol. 2008, 295, R1370–R1375.
   PubMed Web of Science ®Google Scholar
• Briggs, D.I.; Andrews, Z.B. Metabolic status regulates ghrelin function on energy homeostasis. Neuroendocrinology 2011, 93, 48–57.
   PubMed Web of Science ®Google Scholar
• Balthasar, N.; Coppari, R.; McMinn, J.; Liu, S.M.; Lee, C.E.; Tang, V.; Kenny, C.D.; McGovern, R.A.; Chua Jr, S.C.; Elmquist, J.K.; Lowell, B.B. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron. 2004, 42, 983–991.
   PubMed Web of Science ®Google Scholar
• Shi, H.; Sorrell, J.E.; Clegg, D.J.; Woods, S.C.; Seeley, R.J. The roles of leptin receptors on POMC neurons in the regulation of sex-specific energy homeostasis. Physiol. Behav. 2010, 100, 165–172.
   PubMed Web of Science ®Google Scholar
• van de Wall, E.; Leshan, R.; Xu, A.W.; Balthasar, N.; Coppari, R.; Liu, S.M.; Jo, Y.H.; MacKenzie, R.G.; Allison, D.B.; Dun, N.J. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 2008, 149, 1773–1785.
   PubMed Web of Science ®Google Scholar
• Ring, L.E.; Zeltser, L.M. Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels. J. Clin Invest. 2010, 120, 2931–2941.
   PubMed Web of Science ®Google Scholar
• Elias, C.F.; Lee, C.; Kelly, J.; Aschkenasi, C.; Ahima, R.S.; Couceyro, P.R.; Kuhar, M.J.; Saper, C.B.; Elmquist, J.K. Leptin Activates Hypothalamic CART Neurons Projecting to the Spinal Cord. Neuron. 1998, 21, 1375–1385.
   PubMed Web of Science ®Google Scholar
• Hahn, T.M.; Breininger, J.F.; Baskin, D.G.; Schwartz, M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1998, 1, 271–272.
   PubMed Web of Science ®Google Scholar
• Satoh, N.; Ogawa, Y.; Katsuura, G.; Hayase, M.; Tsuji, T.; Imagawa, K.; Yoshimasa, Y.; Nishi, S.; Hosoda, K.; Nakao, K. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci. Lett. 1997, 224, 149–152.
   PubMed Web of Science ®Google Scholar
• Luckett, B.S.; Frielle, J.L.; Wolfgang, L.; Stocker, S.D. Arcuate nucleus injection of an anti-insulin affibody prevents the sympathetic response to insulin. Am. J. Physiol.-Heart Circul. Physiol. 2013, 304, H1538–H1546.
   Google Scholar
• Colley, D.L.; Castonguay, T.W. Effects of sugar solutions on hypothalamic appetite regulation. Physiol. Behav. 2014.
   PubMed Web of Science ®Google Scholar
• Purnell, J.Q.; Klopfenstein, B.A.; Stevens, A.A.; Havel, P.J.; Adams, S.H.; Dunn, T.N.; Krisky, C.; Rooney, W.D. Brain functional magnetic resonance imaging response to glucose and fructose infusions in humans. Diabetes, Obesity Metabol. 2011, 13, 229–234.
   Web of Science ®Google Scholar
• Stellar, E. The physiology of motivation. Psychol. Rev. 1954, 61, 5.
   PubMed Web of Science ®Google Scholar
• Weingarten, H.P.; Chang, P.; McDonald, T. Comparison of the metabolic and behavioral disturbances following paraventricular-and ventromedial-hypothalamic lesions. Brain Res. Bull. 1985, 14, 551–559.
   PubMed Web of Science ®Google Scholar
• Grill, H.J.; Hayes, M.R. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metabol. 2012, 16, 296–309.
   PubMed Web of Science ®Google Scholar
• Kruse, M.S.; Rey, M.; Vega, M.C.; Coirini, H. Alterations of LXRα and LXRβ expression in the hypothalamus of glucose-intolerant rats. J. Endocrinol. 2012, 215, 51–58.
   PubMed Web of Science ®Google Scholar
• Burmeister, M.A.; Ayala, J.; Drucker, D.J.; Ayala, J.E. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose. Am. J. Physiol. - Endocrinol. Metabol. 2013, 304, E677–E685.
   Google Scholar
• Cha, S.H.; Wolfgang, M.; Tokutake, Y.; Chohnan, S.; Lane, M.D. Differential effects of central fructose and glucose on hypothalamic malonyl–CoA and food intake. Proc. Natl. Acad. Sci. 2008, 105, 16871–16875.
   PubMed Web of Science ®Google Scholar
• Hu, Z.; Cha, S.H.; Chohnan, S.; Lane, M.D. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc. Natl. Acad. Sci. 2003, 100, 12624–12629.
   PubMed Web of Science ®Google Scholar
• Cha, S.H.; Lane, M.D. Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway. Biochem. Biophys. Res. Commun. 2009, 386, 212–216.
   PubMed Web of Science ®Google Scholar
• Zhao, C.; Campbell, E.S.; Tschiffely, A.E.; Castonguay, T.W. Overnight Access to Sugar Solutions Affects mRNA Expression of Several Neuropeptides in Different Hypothalamic Regions in Rats. J. Food Nutr. Res. 2015, 3, 69–76.
   Google Scholar
• Chen, H.; Kent, S.; Morris, M.J. Is the CCK2 receptor essential for normal regulation of body weight and adiposity? Eur. J. Neurosci. 2006, 24, 1427–1433.
   Web of Science ®Google Scholar
• Schwartz, G.J.; Whitney, A.; Skoglund, C.; Castonguay, T.W.; Moran, T.H. Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am. J. Physiol.-Regulatory, Integ. Comp. Physiol. 1999, 277, R1144–R1151.
   Google Scholar
• Weiland, T.J.; Voudouris, N.J.; Kent, S. The role of CCK2 receptors in energy homeostasis: insights from the CCK2 receptor-deficient mouse. Physiol. Behav. 2004, 82, 471–476.
   PubMed Web of Science ®Google Scholar
• Chen, J.; Scott, K.A.; Zhao, Z.; Moran, T.H.; Bi, S. Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration. Neuroscience 2008, 152, 178–188.
   PubMed Web of Science ®Google Scholar
• Tebbe, J.; Mönnikes, H.; Pluntke, K.; Bauer, C.; Arnold, R. Cholecystokinin (CCK) microinfused into the paraventricular nucleus of the hypothalamus (PVN) inhibits gastric emptying and stimulates colonic motor activity in the conscious rat. Gastroenterology 1998, 114, A1184–A1185.
   Google Scholar
• Zhu, G.; Yan, J.; Smith, W.W.; Moran, T.H.; Bi, S. Roles of dorsomedial hypothalamic cholecystokinin signaling in the controls of meal patterns and glucose homeostasis. Physiol. Behav. 2012, 105, 234–241.
   PubMed Web of Science ®Google Scholar
• Gahete, M.D.; Córdoba-Chacón, J.; Luque, R.M.; Kineman, R.D. The rise in growth hormone during starvation does not serve to maintain glucose levels or lean mass but is required for appropriate adipose tissue response in female mice. Endocrinology 2012, 154, 263–269.
   PubMed Web of Science ®Google Scholar
• Sakharova, A.A.; Horowitz, J.F.; Surya, S.; Goldenberg, N.; Harber, M.P.; Symons, K.; Barkan, A. Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting. J. Clin. Endocrinol. Metabol. 2008, 93, 2755–2759.
   PubMed Web of Science ®Google Scholar
• De Souza, C.T.; Araujo, E.P.; Bordin, S.; Ashimine, R.; Zollner, R.L.; Boschero, A.C.; Saad, M.J.; Velloso, L.c.A. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146, 4192–4199.
   PubMed Web of Science ®Google Scholar
• Swaroop, J.J.; Rajarajeswari, D.; Naidu, J. Association of TNF-α with insulin resistance in type 2 diabetes mellitus. Indian J. Med. Res. 2012, 135, 127.
   PubMed Web of Science ®Google Scholar
• Wang, X.; Ge, A.; Cheng, M.; Guo, F.; Zhao, M.; Zhou, X.; Liu, L.; Yang, N. Increased hypothalamic inflammation associated with the susceptibility to obesity in rats exposed to high-fat diet. Exp. Diabetes Res. 2012, 2012.
   Google Scholar
• Bleich, S.N.; Wang, Y.C.; Wang, Y.; Gortmaker, S.L. Increasing consumption of sugar-sweetened beverages among US adults: 1988–1994 to 1999—2004. Am. J. Clin. Nutr. 2009, 89, 372–381.
   PubMed Web of Science ®Google Scholar